366 related articles for article (PubMed ID: 33467659)
1. Effects of High Glucose and Lipotoxicity on Diabetic Podocytes.
Nakamichi R; Hayashi K; Itoh H
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33467659
[TBL] [Abstract][Full Text] [Related]
2. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
3. Podocyte hypertrophy in diabetic nephropathy.
Kim NH
Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of podocyte injury and implications for diabetic nephropathy.
Barutta F; Bellini S; Gruden G
Clin Sci (Lond); 2022 Apr; 136(7):493-520. PubMed ID: 35415751
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
6. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases.
Toffoli B; Zennaro C; Winkler C; Giordano Attianese GMP; Bernardi S; Carraro M; Gilardi F; Desvergne B
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1154-F1165. PubMed ID: 29488390
[TBL] [Abstract][Full Text] [Related]
7. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
8. Podocytes as a target of prorenin in diabetes.
Sakoda M; Itoh H; Ichihara A
Curr Diabetes Rev; 2011 Jan; 7(1):17-21. PubMed ID: 21067509
[TBL] [Abstract][Full Text] [Related]
9. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
10. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
Brosius FC; Coward RJ
Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
[TBL] [Abstract][Full Text] [Related]
12. Grem2 mediates podocyte apoptosis in high glucose milieu.
Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
[TBL] [Abstract][Full Text] [Related]
13. Podocyte biology in diabetic nephropathy.
Li JJ; Kwak SJ; Jung DS; Kim JJ; Yoo TH; Ryu DR; Han SH; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
Kidney Int Suppl; 2007 Aug; (106):S36-42. PubMed ID: 17653209
[TBL] [Abstract][Full Text] [Related]
14. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Int J Biol Sci; 2022; 18(1):96-111. PubMed ID: 34975320
[No Abstract] [Full Text] [Related]
15. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling and podocyte dysfunction in diabetic nephropathy.
Bose M; Almas S; Prabhakar S
J Investig Med; 2017 Dec; 65(8):1093-1101. PubMed ID: 28935636
[TBL] [Abstract][Full Text] [Related]
19. Glomerular podocytes in diabetic renal disease.
Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
[TBL] [Abstract][Full Text] [Related]
20. Renal podocyte apoptosis in Zucker diabetic fatty rats: involvement of methylglyoxal-induced oxidative DNA damage.
Kim J; Sohn E; Kim CS; Kim JS
J Comp Pathol; 2011 Jan; 144(1):41-7. PubMed ID: 20541219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
